Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Observe Medical ASA ( (DE:OM50) ).
Observe Medical ASA has announced the approval of a prospectus by the Norwegian Financial Supervisory Authority for the listing of new shares on Euronext Expand, following a successful private placement raising NOK 36,445,000. The company is set to commence a Subsequent Offering of up to 24,000,000 new shares, aiming to raise an additional NOK 12,000,000 in gross proceeds, with the subscription period starting on 26 September 2025. This move is expected to enhance the company’s financial position and support its growth strategy in the medtech industry.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company headquartered in Oslo, Norway, that develops, markets, and sells innovative medical technology products globally. The company focuses on improving patient welfare and clinical data accuracy, primarily through products related to urine measurement and ultrasound, leveraging its expertise in sales and commercialization.
Average Trading Volume: 234,319
Current Market Cap: NOK75.56M
For an in-depth examination of OM50 stock, go to TipRanks’ Overview page.